Is PLRZ or PMCB more undervalued in 2026?

CirclFi compares Polyrizon Ltd. (PLRZ) and PharmaCyte Biotech, Inc. (PMCB) using 13 institutional-grade valuation models. PLRZ has a Quality of Company score of 2.3/10 while PMCB scores 5.1/10.

Which is a better buy — PLRZ or PMCB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PLRZ and PMCB valuations compare?

PLRZ at $16.50 and PMCB at $0.86 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PLRZ vs PMCB Valuation Comparison 2026 — Intrinsic Value Analysis

PLRZ

Biotechnology

Polyrizon Ltd.

Quality

2.3

out of 10

Value Trap

—

Price

$16.50

Last close

Models

9/13

Active

PMCB

Biotechnology

PharmaCyte Biotech, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$0.86

Last close

Models

4/13

Active

Model-by-Model Comparison

Model	Type	PLRZ Fair Value	PLRZ Upside	PMCB Fair Value	PMCB Upside
Bayesian DCF	Intrinsic	$4.37	-73.5%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$19.83	+44.3%	$5.13	+498.5%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$6.53	-60.4%	$2.46	+186.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$18.67	+13.1%	—	—
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PLRZ vs PMCB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PLRZ vs PMCB — Which Stock Is More Undervalued?

PMCB scores higher with a 5.1/10 quality rating vs PLRZ's 2.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Polyrizon Ltd. (PLRZ) and PharmaCyte Biotech, Inc. (PMCB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PLRZ currently trades at $16.50 with a QOC of 2.3/10, while PMCB trades at $0.86 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).